Skip to main content
. 2015 Aug 27;2015:307943. doi: 10.1155/2015/307943

Table 1.

Response to neoadjuvant chemotherapy in 92 patients with NPC.

Response Number of patients
NP
(n = 92)
LN
(n = 80)
Combination
(NP + LN)
Responders
 Complete response 24 (26.1%) 44 (55.0%) 20 (21.7%)
 Partial response 55 (59.8%) 26 (32.5%) 56 (60.9%)
Nonresponders
 Stable disease 13 (14.1%) 10 (12.5%) 16 (17.4%)
 Progressive disease 0 (0%) 0 (0%) 0 (0%)

NP = nasopharynx; LN = regional neck lymph nodes.

12 patients with N0 disease were not included in the analysis.